Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Pharma lobby group opposes senators proposal to lower drug prices: Report

      Pharma lobby group opposes senators' proposal to lower drug prices: Report

      Farhat Nasim26 July 2019 9:00 AM IST
      The proposal aims to lower drug prices by forcing pharmaceutical companies to pay rebates to Medicare if they raise prices above the rate of...
      Man dies after Pharmacist administers painkiller injection; case booked

      Man dies after Pharmacist administers painkiller injection; case booked

      Farhat Nasim25 July 2019 4:44 PM IST
      Chennai: A 52 years old pharmacist has been arrested following the death of a man who was administered a painkiller injection by him. According to...
      Dr Reddys unveils generic version of Rozerem Tablets in US for treating insomnia

      Dr Reddys unveils generic version of Rozerem Tablets in US for treating insomnia

      Farhat Nasim24 July 2019 9:35 AM IST
      The product is a therapeutically equivalent generic version of Rozerem (ramelteon, 8 mg) Tablets, approved by the U.S. Food and Drug Administration...
      Government BANS use of decade old antibiotic COLISTIN in animal feeding, fishing

      Government BANS use of decade old antibiotic COLISTIN in animal feeding, fishing

      Farhat Nasim22 July 2019 3:24 PM IST
      New Delhi: Through a recent Gazette notification, the Union Health Ministry has imposed a ban on popular antibiotic Colistin and its formulations in...
      DOP rejects Mylan review application for revising retail price of Hepatitis B, HIV drug

      DOP rejects Mylan review application for revising retail price of Hepatitis B, HIV drug

      Farhat Nasim18 July 2019 3:58 PM IST
      New Delhi: Through a recent decision, the Department of Pharmaceuticals has rejected the review application filed by Mylan Pharmaceuticals Private...
      Over 10 lakh tablets of habit forming painkiller Tramadol seized, Chemist held

      Over 10 lakh tablets of habit forming painkiller Tramadol seized, Chemist held

      Farhat Nasim18 July 2019 12:07 PM IST
      Mohali: In a major crackdown, the Punjab Police recently busted an illegal racket running from a chemist shop and seized more than 10 lakh Tramadol...
      Methodology to Fix Prices of Essential Medicines- Minister informs Parliament

      Methodology to Fix Prices of Essential Medicines- Minister informs Parliament

      Farhat Nasim17 July 2019 4:07 PM IST
      New Delhi: Through a recent reply, the Minister in the Ministry of Chemical and Fertilizers informed the Parliament about the details of the...
      USFDA finds adulteration, violations of CGMP regulations at Strides Pharma Puducherry plant

      USFDA finds adulteration, violations of CGMP regulations at Strides Pharma Puducherry plant

      Farhat Nasim17 July 2019 1:59 PM IST
      The FDA's warning letter dated July 1, comes months after several Indian drugmakers including Sun Pharmaceutical Ltd and Dr Reddy's Laboratories Ltd...
      Cipla, Jiangsu Acebright join hands to invest USD 30 million for respiratory products in China

      Cipla, Jiangsu Acebright join hands to invest USD 30 million for respiratory products in China

      Farhat Nasim16 July 2019 1:53 PM IST
      While Cipla EU will hold 80 per cent stake in the joint venture, the rest 20 per cent will be with Acebright, the statement by Cipla said. Mumbai:...
      Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat

      Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat

      Farhat Nasim15 July 2019 2:52 PM IST
      New Delhi: The Delhi High Court recently junked the injunction petition filed by the German Drugmaker to restrain the Hyderabad-based Natco Pharma...
      Sun Pharma unveils Ezallor Sprinkle capsules for treating lipid disorder in US

      Sun Pharma unveils Ezallor Sprinkle capsules for treating lipid disorder in US

      Farhat Nasim15 July 2019 2:40 PM IST
      Ezallor Sprinkle (rosuvastatin) capsules are indicated for three types of lipid disorders in conjunction with diet in adults, Sun Pharma said in a...
      Rejected: JnJ plea to waiver Phase IV trial for FDC drug containing Canagliflozin, Metformin

      Rejected: JnJ plea to waiver Phase IV trial for FDC drug containing Canagliflozin, Metformin

      Farhat Nasim14 July 2019 11:30 AM IST
      New Delhi: American multinational drug maker Johnson and Johnson's (JnJ) proposal for waiver of Phase IV clinical trial of its Fixed-Dose Combination...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok